US growth may be a bit bumpy due to healthcare reforms
UK growth won't see immediate revenue but will see ongoing and higher revenue due to model
R&D and expenses due to international growth
Overall, solid report and Nanosonics focused on long term dominant position instead of short term bottom line - how it should be!
Another brick in the wall, page-15
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.01 |
Change
-0.010(0.33%) |
Mkt cap ! $912.0M | |||
| Open | High | Low | Value | Volume |
| $3.02 | $3.05 | $2.97 | $970.6K | 322.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11167 | $3.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.03 | 2142 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| NAN (ASX) Chart |